[144] Health Catalyst, Inc SEC Filing

Rhea-AI Filing Summary

Health Catalyst, Inc. (HCAT) filing of Form 144 notifies the market that 2,613 shares of common stock will be offered for sale through Morgan Stanley Smith Barney on 09/02/2025. The filing lists an aggregate market value of $8,786.74 for the shares based on the transaction and shows 70,373,625 shares outstanding for the issuer.

The shares were acquired the same day, 09/02/2025, as restricted stock from Health Catalyst and are identified as compensation. The filer discloses a prior restricted-stock sale of 2,712 shares on 06/02/2025 yielding gross proceeds of $9,857.58. By signing, the person attests they are unaware of undisclosed material adverse information about the issuer.

Positive

• Complete Rule 144 disclosure including broker, share count, market value, acquisition details, and prior sales
• Attestation present that the filer does not possess undisclosed material adverse information
• Transaction tied to compensation, and acquisition date is explicitly stated as 09/02/2025

Negative

• None.

Insights

Securities Analyst

TL;DR: This Form 144 is a routine insider sale notice disclosing a small compensation-related sale of 2,613 shares.

The filing contains standard Rule 144 disclosure: broker details (Morgan Stanley Smith Barney), number of shares (2,613), aggregate market value ($8,786.74), and outstanding share count (70,373,625). The securities were acquired as restricted stock on the sale date and were paid as compensation, which indicates these are proceeds from an insider compensation event rather than a market purchase. The filing also lists a recent prior restricted-stock sale of 2,712 shares on 06/02/2025 for $9,857.58, which provides context on recent insider liquidity. No earnings, material contracts, or regulatory issues are disclosed here.

Corporate Governance Expert

TL;DR: Disclosure appears complete for a Rule 144 notice; signature attestation confirms no undisclosed material information.

The document includes required information: relationship to issuer (implicit through compensation), acquisition date and nature (restricted stock), nature of payment (compensation), broker, and planned sale date. The signer affirms absence of material nonpublic information in the issuer, a standard legal attestation. The filing does not include any governance changes, insider departures, or other corporate actions.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC 1 New York Plaza, 38th Floor New York NY 10004	2613	8786.74	70373625	09/02/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/02/2025	Restricted Stock	Health Catalyst, Inc.			2613	09/02/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jason Alger c/o 10897 South River From Parkway #300 South Jordan UT 84095	Restricted Stock	06/02/2025	2712	9857.58

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for Health Catalyst (HCAT) report?

The form reports an intended sale of 2,613 common shares through Morgan Stanley Smith Barney on 09/02/2025 with an aggregate market value of $8,786.74.

How were the 2,613 shares acquired by the filer?

The shares were acquired on 09/02/2025 as restricted stock from Health Catalyst and were granted as compensation.

Has the filer sold other Health Catalyst shares recently?

Yes. The filing discloses a prior sale of 2,712 restricted shares on 06/02/2025 for gross proceeds of $9,857.58.

What broker will handle the sale listed in the Form 144?

The broker named is Morgan Stanley Smith Barney LLC, located at 1 New York Plaza, 38th Floor, New York, NY 10004.

Does the filing indicate any undisclosed material information about Health Catalyst?

No. The signer expressly represents that they do not know of any material adverse information about the issuer that has not been publicly disclosed.